Join
Live feed
·
INSIDERFilingvia Quantisnow
TCR2 Therapeutics Inc. logo

SEC Form 4: Menzel Garry E sold $23,360 worth of shares (18,425 units at $1.27) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 170,809 units to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRR (TCR2 Therapeutics Inc.) and more on Quantisnow.